Search hospitals > California > Santa Monica
John Wayne Cancer Institute
Claim this profileSanta Monica, California 90404
Global Leader in Melanoma
Global Leader in Breast Cancer
Conducts research for Cancer
Conducts research for Brain Tumor
Conducts research for Tumors
98 reported clinical trials
4 medical researchers
Summary
John Wayne Cancer Institute is a medical facility located in Santa Monica, California. This center is recognized for care of Melanoma, Breast Cancer, Cancer, Brain Tumor, Tumors and other specialties. John Wayne Cancer Institute is involved with conducting 98 clinical trials across 77 conditions. There are 4 research doctors associated with this hospital, such as Janie G. Weng Grumley, Parvin Peddi, MD, Przemyslaw Twardowski, MD, and Robert Wollman, MD.Area of expertise
1Melanoma
Global LeaderStage IV
Stage III
BRAF positive
2Breast Cancer
Global LeaderHER2 positive
Stage III
Stage II
Top PIs
Janie G. Weng GrumleySaint John's Cancer Institute5 years of reported clinical research
Studies Breast Cancer
Studies Intra-Operative Radiation Therapy
5 reported clinical trials
9 drugs studied
Parvin Peddi, MDSaint John's Cancer Institute2 years of reported clinical research
Studies Breast Cancer
Studies Cancer
5 reported clinical trials
14 drugs studied
Przemyslaw Twardowski, MDJohn Wayne Cancer Institute2 years of reported clinical research
Studies Prostate Cancer
Studies Ovarian Cancer
4 reported clinical trials
12 drugs studied
Robert Wollman, MDJohn Wayne Cancer Institute6 years of reported clinical research
Studies Ductal Carcinoma
Studies Lobular Carcinoma in Situ
3 reported clinical trials
4 drugs studied
Clinical Trials running at John Wayne Cancer Institute
Breast Cancer
Prostate Cancer
Cancer
Solid Tumors
Tumors
Endometrial Cancer
Bladder Cancer
Ovarian Cancer
Cognitive Impairment
Renal Cell Carcinoma
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at John Wayne Cancer Institute?
John Wayne Cancer Institute is a medical facility located in Santa Monica, California. This center is recognized for care of Melanoma, Breast Cancer, Cancer, Brain Tumor, Tumors and other specialties. John Wayne Cancer Institute is involved with conducting 98 clinical trials across 77 conditions. There are 4 research doctors associated with this hospital, such as Janie G. Weng Grumley, Parvin Peddi, MD, Przemyslaw Twardowski, MD, and Robert Wollman, MD.